Does Nitroglycerin Infusion Affect Heart Rate?
Yes, intravenous nitroglycerin typically increases heart rate as a reflexive compensatory response to the blood pressure reduction it causes. This is a well-established hemodynamic effect documented in both FDA labeling and clinical guidelines.
Mechanism of Heart Rate Increase
Nitroglycerin causes vasodilation, particularly of venous capacitance vessels, which reduces preload and subsequently lowers blood pressure. The heart rate usually increases as a baroreceptor-mediated reflex response to maintain cardiac output in the face of falling blood pressure 1. This reflexive tachycardia can partially offset nitroglycerin's beneficial reduction in myocardial oxygen demand.
Clinical Evidence
The FDA labeling explicitly states: "The heart rate was usually increased, presumably as a reflexive response to the fall in blood pressure" during therapeutic doses of intravenous nitroglycerin 1. This effect was consistently observed across multiple open-label studies where nitroglycerin reduced both systolic and diastolic blood pressure.
Clinical trial data confirms this pattern. In patients with chronic stable angina receiving continuous IV nitroglycerin infusions, there was a sustained rise in heart rate at rest that persisted throughout 24 hours of infusion 2.
Important Clinical Context
When Beta Blockers Are Co-administered
The 2014 AHA/ACC guidelines note that nitroglycerin's reflex increases in heart rate and contractility may be counteracted when a beta blocker is concurrently administered 3. This combination can optimize the reduction in myocardial oxygen consumption by preventing the compensatory tachycardia.
Effect on Morphine
Conversely, morphine sulfate—which may be used alongside nitroglycerin for refractory angina—produces modest reductions in heart rate through increased vagal tone 3. This creates an opposing effect to nitroglycerin's tendency to increase heart rate.
Clinical Implications and Monitoring
- Expect heart rate to rise when initiating IV nitroglycerin, particularly in patients not on beta blockers
- Monitor for excessive tachycardia that could worsen myocardial ischemia by increasing oxygen demand
- Avoid nitroglycerin in patients with marked tachycardia at baseline 4
- The combination of blood pressure reduction plus tachycardia can compromise coronary perfusion pressure in some patients
- Consider concurrent beta blockade to blunt the reflex tachycardia and optimize anti-ischemic effects
Dosing Considerations
Recent evidence suggests that higher doses of IV nitroglycerin (≥100 mcg/min) achieve faster symptom resolution in acute pulmonary edema without increased hypotension risk 5, 6. However, the reflexive heart rate increase may be more pronounced at higher infusion rates due to greater blood pressure reduction, though this specific dose-response relationship for heart rate is not well-quantified in the literature.